Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation

Heart Vessels. 2014 Mar;29(2):273-7. doi: 10.1007/s00380-013-0350-1. Epub 2013 Apr 18.

Abstract

A 60-year-old man who had received repeated angioplasty for silent ischemia was suspected to have restenosis based on radioisotope imaging (exercise-RI) findings 6 months after everolimus-eluting stent (EES) implantation (3.5 × 28, 3.5 × 28, 3.0 × 18 mm). The stents had been implanted for chronic total occlusion of the right coronary artery (RCA), and the patient was on continuous dual antiplatelet therapy. Diagnostic angiography demonstrated in-stent restenosis in the proximal RCA, which was treated by optical coherence tomography (OCT)-guided cutting balloon angioplasty with distal protection. OCT findings of the stenotic segment before angioplasty showed that the lesion had complex features. The lesion was successfully dilated, and whitish material obtained by a distal protection device was composed of fibrin thrombi with neutrophils and small pieces of mature fibrocellular neointima. The mechanisms and patterns of restenosis after EES placement have not been well clarified. This case may reflect a restenosis pattern (i.e., asymptomatic, focal, and thrombi-related) in the era of the newer generation of drug-eluting stents.

Publication types

  • Case Reports

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Cardiovascular Agents / administration & dosage*
  • Coronary Angiography
  • Coronary Restenosis / diagnosis
  • Coronary Restenosis / etiology*
  • Coronary Restenosis / therapy
  • Coronary Thrombosis / diagnosis
  • Coronary Thrombosis / etiology*
  • Coronary Thrombosis / therapy
  • Drug-Eluting Stents*
  • Everolimus
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / adverse effects*
  • Percutaneous Coronary Intervention / instrumentation*
  • Prosthesis Design
  • Severity of Illness Index
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives*
  • Tomography, Optical Coherence
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Everolimus
  • Sirolimus